EDGAR Filing Documents for 0001104659-20-024077

Form 8-K - Current report:

SEC Accession No. 0001104659-20-024077

Filing Date

2020-02-24

Accepted

2020-02-24 07:19:07

Documents

Period of Report

2020-02-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm209736-1_8k.htm	8-K	31767
2	EXHIBIT 3.1	tm209736d1_ex3-1.htm	EX-3.1	69630
3	EXHIBIT 10.1	tm209736d1_ex10-1.htm	EX-10.1	478531
4	EXHIBIT 10.2	tm209736d1_ex10-2.htm	EX-10.2	161539
5	EXHIBIT 99.1	tm209736d1_ex99-1.htm	EX-99.1	14315
6	GRAPHIC	tm209736d1_ex99-1img01.jpg	GRAPHIC	6328
	Complete submission text file	0001104659-20-024077.txt		766094

Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005

Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830

AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 20642047
SIC: 2834 Pharmaceutical Preparations